Posted 3/8/2024, 4:28:00 PM
Novo Nordisk Soars Past Tesla in Value on Weight Loss Drug Promise
- Novo Nordisk, maker of diabetes and weight loss drugs Ozempic and Wegovy, is now more valuable than Tesla
- Novo Nordisk's stock surged after positive trial results for an experimental weight loss pill
- Demand for weight loss drugs is booming while electric vehicle growth shows signs of slowing
- Novo Nordisk is fueling economic growth in its native Denmark
- Novo Nordisk and competitor Eli Lilly dominate the weight loss drug market amid supply shortages